From June 16 to 18, 2017, the "eighth academic annual meeting of the World Federation of Chinese Medicine Analysis Professional Committee and the international academic conference of Chinese medicine analysis" was successfully held in Beijing Kuntai Hotel. More than 50 experts and representatives from the experts of the Chinese medicine standardization project of the State Administration of traditional Chinese medicine, relevant experts of the national pharmacopoeia committee, European Pharmacopoeia and domestic and foreign scientific research institutes attended the meeting, which was co sponsored by the professional committee of Chinese medicine analysis of the World Federation of Chinese medicine and the National Engineering Laboratory of Chinese medicine standardization technology (Shanghai Institute of Materia Medica, Chinese Academy of Sciences), organized by Beijing University of traditional Chinese medicine and Agilent Technology Co., Ltd. and co organized by Chengdu biopurify pharmaceuticals Ltd.and make special reports of the Congress. Biopurify technology, as one of the co sponsors, sponsored and attended the conference.
The professional committee of traditional Chinese medicine analysis of the World Federation of traditional Chinese Medicine Societies was officially established in july2010. Adhering to the guiding ideology of academic activities of "combining with practice, cooperating with enterprises, developing new technologies and methods, strengthening international exchanges, and serving the improvement of Pharmacopoeia standards", the special committee is committed to promoting the standardization and standardization of the production, use and management of traditional Chinese medicine and prepared pieces of traditional Chinese medicine, promoting the research and development of new traditional Chinese medicine, and accelerating the industrialization of traditional Chinese medicine.
President Xie and his wife of the company took a group photo with Professor guode'an, chairman of the conference
Group photo of senior management of the company with Professor tupengfei, chairman of the conference
Chengdu biopurify pharmaceuticals Ltd. is mainly engaged in the production, customization and production process development of high-purity traditional Chinese medicine chemical components, traditional Chinese medicine reference substances, high-quality extracts, natural product intermediates for new drug research and development, drug impurities and fine chemicals, serving global scientific research institutions, universities and various end customers. After several years of research and development, biopurifyTraditional Chinese medicine component library(compound library of TCM; natural product compound library) there are more than 4600 compounds, many of which are unique to us.With excellent quality and good service, our customers have spread over more than 50 countries and regions in the world. It is a stable supplier of sigma, chromadex, DSM and other large international companies; It has established a good cooperative relationship with the United States Pharmacopeia Committee and the European Pharmacopeia Committee in the research and supply of herbal quality standards and standards.
During the meeting, experts and scholars came to the company booth for consultation and exchange
